| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
32,549,000 |
| Market
Cap: |
5.05(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$125.26 - $326.08 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Inspire Medical Systems is a medical technology company focused on the development and commercialization of solutions for patients with obstructive sleep apnea (OSA). Co.'s proprietary Inspire system is the U.S. Food and Drug Administration-approved neurostimulation technology that provides a treatment for moderate to severe OSA. Co. has developed a solution that monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Co. sells its Inspire system to hospitals and ambulatory surgery centers in the U.S. and in select countries in Europe through a direct sales organization, and Co. sells its Inspire system in Japan through a distributor.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
100 |
100 |
| Total Buy Value |
$0 |
$0 |
$15,350 |
$15,350 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
125,530 |
125,530 |
179,341 |
331,760 |
| Total Sell Value |
$25,509,709 |
$25,509,709 |
$27,305,908 |
$147,742,596 |
| Total People Sold |
5 |
5 |
5 |
8 |
| Total Sell Transactions |
12 |
12 |
24 |
46 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Herbert Timothy P. |
CEO and President |
• • – |
2020-12-23 |
4 |
GA |
$0.00 |
$0 |
D/D |
20,717 |
171,119 |
|
- |
|
| Herbert Timothy P. |
CEO and President |
• • – |
2020-12-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
85,638 |
0 |
|
- |
|
| Buchholz Richard |
Chief Financial Officer |
• – – |
2020-12-15 |
4 |
AS |
$185.00 |
$571,589 |
D/D |
(3,000) |
65,651 |
|
24% |
|
| Jandrich Steven |
Chief Comp Off & VP, Human Res |
• – – |
2020-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
300 |
1,505 |
|
- |
|
| Buchholz Richard |
Chief Financial Officer |
• – – |
2020-11-17 |
4 |
AS |
$167.36 |
$514,986 |
D/D |
(3,000) |
68,651 |
|
15% |
|
| Herbert Timothy P. |
CEO and President |
• • – |
2020-11-05 |
4 |
AS |
$162.82 |
$13,099,424 |
I/I |
(80,000) |
122,875 |
|
20% |
|
| Nelson Marilyn C |
Director |
– • – |
2020-11-03 |
4 |
AS |
$144.65 |
$1,012,550 |
I/I |
(7,000) |
138,017 |
|
35% |
|
| Buchholz Richard |
Chief Financial Officer |
• – – |
2020-10-20 |
4 |
AS |
$121.12 |
$368,510 |
D/D |
(3,000) |
71,651 |
|
97% |
|
| Nelson Marilyn C |
Director |
– • – |
2020-10-09 |
4 |
AS |
$130.00 |
$130,000 |
I/I |
(1,000) |
145,017 |
|
79% |
|
| Tansey Casey M |
Director |
– • – |
2020-10-09 |
4 |
A |
$130.00 |
$13,650 |
D/D |
105 |
18,935 |
|
- |
|
| Ellis Gary Lee |
Director |
– • – |
2020-10-09 |
4 |
A |
$130.00 |
$13,650 |
D/D |
105 |
1,636 |
|
- |
|
| Nelson Marilyn C |
Director |
– • – |
2020-10-09 |
4 |
A |
$130.00 |
$20,540 |
D/D |
158 |
3,189 |
|
- |
|
| Melenikiotou Georgia |
Director |
– • – |
2020-10-09 |
4 |
A |
$130.00 |
$11,440 |
D/D |
88 |
88 |
|
- |
|
| Khuong Chau Quang |
Director |
– • – |
2020-10-09 |
4 |
A |
$130.00 |
$11,830 |
D/D |
91 |
1,875 |
|
- |
|
| Buchholz Richard |
Chief Financial Officer |
• – – |
2020-10-09 |
4 |
OE |
$0.94 |
$247,489 |
D/D |
8,267 |
74,651 |
|
- |
|
| Nelson Marilyn C |
Director |
– • – |
2020-10-08 |
4 |
AS |
$129.20 |
$3,273,977 |
I/I |
(25,000) |
146,017 |
|
78% |
|
| Buchholz Richard |
Chief Financial Officer |
• – – |
2020-09-22 |
4 |
AS |
$122.75 |
$756,556 |
D/D |
(6,000) |
66,384 |
|
67% |
|
| Tansey Casey M |
Director |
– • – |
2020-09-14 |
4 |
S |
$128.58 |
$1,551,211 |
D/D |
(12,000) |
18,830 |
|
-56% |
|
| Ban Randy |
Chief Commercial Officer |
• – – |
2020-09-09 |
4 |
AS |
$117.03 |
$3,526,268 |
D/D |
(30,000) |
189 |
|
82% |
|
| Ban Randy |
Chief Commercial Officer |
• – – |
2020-09-09 |
4 |
OE |
$1.14 |
$34,200 |
D/D |
30,000 |
30,189 |
|
- |
|
| Griffin Jerry C |
Director |
– • – |
2020-08-27 |
4 |
S |
$114.67 |
$3,321,732 |
D/D |
(28,800) |
0 |
|
-68% |
|
| Jandrich Steven |
Chief Comp Off & VP, Human Res |
• – – |
2020-08-18 |
4 |
AS |
$110.00 |
$330,000 |
D/D |
(3,000) |
1,805 |
|
71% |
|
| Jandrich Steven |
Chief Comp Off & VP, Human Res |
• – – |
2020-08-18 |
4 |
OE |
$10.38 |
$95,093 |
D/D |
3,000 |
4,805 |
|
- |
|
| Orbimed Capital Gp V Llc |
Director |
– • – |
2020-08-18 |
4 |
S |
$108.54 |
$4,726,157 |
I/I |
(43,543) |
0 |
|
-71% |
|
| Khuong Chau Quang |
Director |
– • – |
2020-08-18 |
4 |
S |
$108.54 |
$4,726,157 |
I/I |
(43,543) |
0 |
|
-71% |
|
565 Records found
|
|
Page 12 of 23 |
|
|
3.81 (2.4%) 
